Jazz Pharmaceuticals Plc

Jazz Pharmaceuticals Plc

Jazz Pharmaceuticals Plc

Overview
Date Founded

2003

Headquarters

Waterloo Exchange,Waterloo Road,Dublin 4

Type of Company

Public

Employees (Worldwide)

1,360

Industries

Pharmaceuticals

Company Description

• About Us • Mission & Values • Management Team • Board of Directors • Board Committees • Commercial Capabilities • Corporate Responsibility • Ethical Sales & Marketing • Drug Safety & Medical Info • Physician Data Restriction Program • California Compliance Declaration • Stories • What’s in a Name? • Business Development • Locations ABOUT US Jazz Pharmaceuticals plc is an international specialty biopharmaceutical company dedicated to helping patients with unmet medical needs. We identify, develop and commercialize innovative products in focused therapeutic areas, with a strong commercial focus and expertise in narcolepsy, oncology, pain and psychiatry. Our marketed product portfolio includes: XYREM® (sodium oxybate), ERWINAZETM (asparaginase Erwinia chrysanthemi), PRIALT® (ziconotide) solution, intrathecal infusion, FAZACLO® (clozapine, USP) LD and HD , and LUVOX CR® (fluvoxamine maleate). The product information on XYREM, ERWINAZE, PRIALT, FAZACLO LD, FAZACLO HD and LUVOX CR is intended only for residents of the United States. For more information, including complete prescribing information and boxed warnings, click on the product names above. Please visit www.EUSAPharma.com for more information about our international division, EUSA Pharma, and our products marketed outside the U.S. We plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our unique commercial expertise. As we evaluate additional acquisition and in-licensing opportunities, we work closely with healthcare professionals and patient advocates to identify significant treatment gaps where Jazz Pharmaceuticals’ unique approach to patient care and patient-focused products may be able to bring a new therapeutic option to the market where none existed previously.

Contact Data
Trying to get in touch with decision makers at Jazz Pharmaceuticals Plc? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

President & Chief Operating Officer

Chief Accounting Officer & Senior Vice President-Finance

Executive Vice President, US Commercial

Executive Vice President, Research & Development

Senior Vice President, Jazz Pharmaceuticals Europe & Rest of World

Senior Vice President, Technical Operations

Vice President, Investor Relations

Senior Director, Investor Relations

Senior Vice President, Associate General Counsel & Chief Compliance Officer

Board of Directors

Lead Corporate Development at Bioaxone Therapeutics, Inc.

UDG Healthcare Plc

Co-Founder at Longitude Capital Management Co. LLC

Chief Executive Officer & Chairman of the Board at Theravance Biopharma, Inc.

Former Managing Director Ireland at Reckitt Benckiser Plc

Venture Partner at ARCH Venture Partners

President, Chief Executive Officer, Director at Aptinyx, Inc.

Secretary at Mindmaze SA

Former Chief Business Officer, International Business Development at Jazz Pharmaceuticals, Inc.

Founder at Beecken Petty O'Keefe & Co. LP

Paths to Jazz Pharmaceuticals Plc
Potential Connections via
Relationship Science
You
Jazz Pharmaceuticals Plc
Owners & Shareholders
Details Hidden

CAM's stock selection is primarily based on a research-driven bottom up approach and implemented using a congressional approach, where each investment strategy is governed by an investment product committee (IPC). The research and recommendation are reviewed, debated and decided upon by the IPC. The firm's research techniques include idea generation and fundamental analysis. Identifying of possible investment opportunities through fundamental analysis and using numerous tools, such as quantitative screening, third-party research reports, periodicals, news articles, direct company meetings, press releases, industry conferences and any other useful and reliable information sources are done by portfolio managers and research analysts. CAM performs their analysis of the companies identified as having the most compelling investment opportunity. The teams validate key quantitative metrics such as earnings growth, cash flows and balance sheet strength and other key factors such as competitive advantages, market leadership, stability of revenue stream, product development and pricing power. The decision to invest is debated within the IPC on its investment merits, its fit within the investment discipline, and its fit within the current portfolio investment mix. CAM's investment philosophy is to maximize potential return per unit of risk using fundamental and relative valuations that employ a combination of top down and bottom up techniques to deliver a consistent pattern of relative returns with minimal periods of underperformance.

Details Hidden

Pictet Asset Management (PAM) is the institutional investment management arm of the Pictet group, one of the leading independent wealth and asset managers in Europe. Pictet Asset Management encompasses all the operating subsidiaries and divisions of the Group dedicated to institutional asset management. We provide specialist investment management solutions to leading financial institutions around the world. Our clients include some of the world's largest pension funds, mutual funds, sovereign wealth funds and financial institutions. At a global level, we manage EUR 115 billion for clients from offices in London, Geneva, Zurich, Singapore and Tokyo. We believe in organic growth and take a long-term view in the best interests of our clients.

Details Hidden

BCM uses statistical analyses and models to select investments for client accounts. The models they use assume that certain historical statistical relationships will continue. These models are constructed based on historical data supplied by third parties and, as a result, the success of relying on such models depend heavily on the accuracy and reliability of the supplied historical data. These models seek to identify both fundamentally and technically undervalued securities. Generally, client accounts are managed in accordance with a specific investment strategy. BCM's strategies include Aggressive Investors 1, Ultra-Small Company, Ultra-Small Company Market, Small-Cap Momentum, Small-Cap Growth, Small-Cap Value, Omni Small-Cap Value, Omni Tax-Managed Small-Cap Value, Large-Cap Growth, Large-Cap Value, Blue Chip 35, Blue Chip 35 Ex-Financials and Managed Volatility.

Recent Transactions
Details Hidden

Jazz Pharmaceuticals Plc purchases Cavion, Inc. from Lilly Ventures Management Co. LLC, Novartis Venture Fund, Center for Innovative Technology, Enso Ventures Ltd.

Details Hidden

Jazz Pharmaceuticals Plc purchases Celator Pharmaceuticals, Inc.

Details Hidden

Jazz Pharmaceuticals Plc purchases Jazz Pharmaceuticals II SASU from Turenne Capital Partenaires SA, Octalfa SAS

Transaction Advisors
Legal Advisor

Advised onJazz Pharmaceuticals Plc purchases Celator Pharmaceuticals, Inc.

Legal Advisor

Advised onJazz Pharmaceuticals Plc purchases Gentium Srl

Underwriter

Advised onJazz Pharmaceuticals Plc issued Ordinary Shares

Legal Advisor

Advised onJazz Pharmaceuticals Plc purchases Celator Pharmaceuticals, Inc.

Legal Advisor

Advised onJazz Pharmaceuticals Plc purchases Gentium Srl

Legal Advisor

Advised onJazz Pharmaceuticals Plc purchases Celator Pharmaceuticals, Inc.

Advisors & Consultants
Legal Advisor

Partner In Charge-Palo Alto at Cooley LLP

Legal Advisor

Partner at Cooley LLP

Legal Advisor

Partner, San Diego at Cooley LLP

Clients

Cigna is more than a health insurance company. They are a global health service company. Cigna works with employers and organizations around the world helping employees stay healthy and on the job. They work closely with brokers and consultants to develop innovative programs, help individuals and families improve their health, well-being and sense of security—and lower their medical costs. And, Cigna provides access to a global network of local physicians and hospitals—as well as 24/7/365 live customer service.

McKesson is dedicated to delivering the vital medicines, medical supplies and information technologies that enable the health care industry to provide patients better, safer care. McKesson is made up of many businesses, all serving the health care industry. Our businesses fall into one of two primary categories: Distribution solutions. We are the largest pharmaceutical distributor in North America, distributing one-third of the medicines used every day. As one of the leading pharmaceutical companies, we supply more than 40,000 U.S. pharmacy locations, from Wal-Mart to the Department of Veterans Affairs to community pharmacies and hospitals. McKesson is also one of the leading medical supply companies and distributes medical-surgical supplies and homecare supplies. Healthcare Technology solutions. We develop and install healthcare information technology systems that eliminate the need for paper prescriptions and paper medical records. Our software and hardware are used in more than 70% of the nation's hospitals with more than 200 beds. Our hospital information system solutions include electronic health record system (EHR) and clinical decision support system such as Interqual. McKesson's Healthcare IT division also serves diverse areas within the health industry by offering solutions such as pharmacy automation and medical claims management software. McKesson publicly traded on NYSE under MCK Businesses Serving our customers—pharmacies, medical and pharmaceutical manufacturers, hospitals, and insurers—as the health care industry evolves is our primary goal. We have business lines to automate processes from medical supplies packaging to claims management, and revenue cycle management to medical imaging. McKesson's long history in pharmaceutical industry History McKesson has a long history in health care. We’ve been a trusted provider of medical supplies and goods for more than 175 years.

Cigna is a global health service company, dedicated to helping the people we serve improve their health, well-being and sense of security. We make this happen through a broad range of integrated health care and related plans and services, and proven health and well-being programs that are targeted to the unique needs of our customers, clients and partners. "At Cigna, we understand that people are unique, and so, too, is their health. In a world of many millions, we see each person defining a healthy life on his or her own terms. It's our aim to be part of that journey, helping people achieve better health and peace of mind along the way." - David Cordani, CEO

Key Stats and Financials As of 2018
Market Capitalization
$8.24B
Total Enterprise Value
$8.36B
Earnings Per Share
$7.3
Revenue
$1.89B
Net Profit
$447M
EBITDA
$875M
EBITDAMargin
46.27%
Total Debt
$1.6B
Total Equity
$2.76B
Enterprise Value Sales
4.42x
Enterprise Value EBITDAOperating
9.56x
TEVNet Income
18.7x
Debt TEV
0.19x
Three Year Compounded Annual Growth Rate Of Revenue
12.59%
Five Year Compounded Annual Growth Rate Of Revenue
16.73%
Investments
Details Hidden

Arrivo BioVentures LLC is a biopharmaceutical company. It develops biologics and small molecules to improve patient lives. The company was founded by Steve Butts, Bill Wofford, Michael Ackermann and Jed Black on July 9, 2015 and is headquartered in Morrisville, NC.

Investors
Details Hidden

Founder at Foresite Capital Management LLC

Suppliers
Concert Pharmaceuticals, Inc. Medical Support Services | Lexington, MA

Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA.

Siegfried Holding AG Pharmaceuticals | Zofingen, AG

Siegfried Holding AG engages in the development and manufacture of active pharmaceutical ingredients for pharmaceutical clients with research and development programs, related intermediates, and controlled substances. It also provides development and production services for finished dosage forms including sterile filling. The company was founded by Samuel Benoni Siegfried in 1873 and is headquartered in Zofingen, Switzerland.

Pfenex, Inc. Pharmaceuticals | San Diego, CA

Pfênex, Inc. is a clinical-stage biotechnology company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes biosimilars and vaccines. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.

Competitors
Roche Holding AG Pharmaceuticals - Basel, BS

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Grifols SA Pharmaceuticals - Barcelona, CT

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Avadel Pharmaceuticals Plc Pharmaceuticals - Dublin, DU

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jazz Pharmaceuticals Plc. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jazz Pharmaceuticals Plc's profile does not indicate a business or promotional relationship of any kind between RelSci and Jazz Pharmaceuticals Plc.